
In the patient with heart failure, strict or tight blood pressure control should be targeted: ideally <140/90mmHg.

Quiz-summary
0 of 15 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Information
You have already completed the module before. Hence you can not start it again.
Module is loading…
You have to finish following quiz, to start this quiz:
Results
Results
Time has elapsed
Categories
- Not categorized 0%
-
Thank you, we will review your submission and notify you of your results via email.
If not received within 5 hours due to spam, don’t worry, it will show in your profile.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Answered
- Review
- Question 1 of 15
1. Question
1. What is the most likely cause of Mrs CT’s clinical symptoms?
- Question 2 of 15
2. Question
2. Which of the following is NOT a common risk factor for the development of PPCM?
- Question 3 of 15
3. Question
3. Which of the following clinical and/or biochemical tests are NOT necessary to make a diagnosis of HFrEF?
- Question 4 of 15
4. Question
4. What is the most likely explanation for the sinus tachycardia in this patient?
- Question 5 of 15
5. Question
5. What is the New York Heart Association (NYHA) classification of Mrs CT on this presentation?
- Question 6 of 15
6. Question
6. Which of the HF therapies that Mr AB is taking will improve his acute symptoms, but will NOT improve his chronic HF morbidity and mortality?
- Question 7 of 15
7. Question
7. What would you do first to optimise Mr AB’s angina symptoms and his HF prognosis?
- Question 8 of 15
8. Question
8. Given that Mr AB deteriorated acutely while on a beta-blocker, RAAS blocker and aldactone, what changes to his therapy would you consider at this stage?
- Question 9 of 15
9. Question
9. What is the target dose for enalapril in a patient with HFrEF?
- Question 10 of 15
10. Question
10. What is the target dose for bisoprolol in a patient with HFrEF?
- Question 11 of 15
11. Question
11. Which other comorbidities are not optimally controlled in this patient?
- Question 12 of 15
12. Question
12. Mr AB’s cardiac troponins were reported as positive. Does this indicate an acute coronary syndrome?
- Question 13 of 15
13. Question
13. During this visit you consider adding ivabradine to help optimise the autonomic dysfunction. Which of the following is not an indication for use of ivabradine?
- Question 14 of 15
14. Question
14. Further, Mr AB reports that he is experiencing breast tissue tenderness and that his breast tissue is enlarging. Which of the following medications is the most likely culprit?
- Question 15 of 15
15. Question
15. To better optimise Mr AB’s medication, you would like to exchange enalapril for an ARNI. What is the absolute minimum duration for the suspension of enalapril treatment before introducing the ARNI (sacubitril-valsartan)?
Do you like this? Share with a colleague
[DISPLAY_ULTIMATE_SOCIAL_ICONS]